Guest guest Posted September 25, 2007 Report Share Posted September 25, 2007 Distal truncation of KCC3 in non–French Canadian HMSN/ACC families A. Salin-Cantegrel, MSc, J. -B. Rivière, MSc, N. Dupré, MD, MSc, F. M. Charron, MSc, M. Shekarabi, PhD, L. Karéméra, C. Gaspar, PhD, J. Horst, MD, M. Tekin, MD, G. Deda, MD, A. Krause, MD, PhD, M. M. Lippert, MD, M. A.A.P. Willemsen, MD, R. Jarrar, MD, J. -Y. Lapointe, PhD and G. A. Rouleau, MD, PhD From the Centre for the Study of Brain Diseases (A.S.-C., J.-B.R., M.S., L.K., C.G., G.A.R.), CHUM Research Centre–Notre-Dame Hospital and the University of Montreal, Québec; Department of Neurological Sciences (N.D.), CHAUQ-Enfant-Jesus, Quebec City; Department of Physics (F.M.C., J.-Y.L.), Université de Montreal, Québec, Canada; Institut fur Humangenetik (J.H.), Universitatsklinikum Munster, Germany; Pediatric Molecular Genetics Department (M.T., G.D.), Ankara University, School of Medicine, Turkey; Department of Human Genetics (A.K., M.M.L.), National Health Laboratory Service and University of Witwatersand, South Africa; Department of Paediatric Neurology (M.A.A.P.W.), University Medical Centre, St. Radboud, Nijmegen, The Netherlands; and Gillette Children's Specialty Health Care (R.J.), St. , MN. Background: Hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC) is a severe and progressive autosomal recessive polyneuropathy. Mutations in the potassium-chloride cotransporter 3 gene (KCC3) were identified as responsible for HMSN/ACC in the French Canadian (FC) population. In the present study, the authors were interested in finding new mutations in non- FC populations, assessing the activity of mutant proteins and refining genotype-phenotype correlations. Methods: The authors screened KCC3 for mutations using direct sequencing in six non-FC HMSN/ACC families. They then assessed the functionality of the most common mutant protein using a flux assay in Xenopus laevis oocytes. Results: The authors identified mutations in exon 22 of KCC3: a novel mutation (del + 2994-3003; E1015X) in one family, as well as a known mutation (3031CT; R1011X) found in five unrelated families and associated with two different haplotypes. The function of the cotransporter was abolished, although a limited amount of mutant proteins were correctly localized at the membrane. Conclusions: KCC3 mutations in exon 22 constitute a recurrent mutation site for hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC), regardless of ethnic origin, and are the most common cause of HMSN/ACC in the non–French Canadian (FC) families analyzed so far. Therefore, for genetic analysis, exon 22 screening should be prioritized in non-FC populations. Finally, the R1011X mutation leads to the abrogation of KCC3's function in Xenopus laevis oocytes, likely due to impaired transit of the cotransporter. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.